Modulation of EGF receptor by tumor necrosis factor-α in human hepatocellular carcinoma HepG2 cells

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 3001-3006

  Wang, Dongfang ^a   Yang, Er Bin ^a   Cheng, Li Yao ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Affinity of EGF receptor; Degradation; Epidermal growth factor receptor; Internalization; Tumor necrosis factor; Tyrosine phosphorylation

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ARTICLE; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY;

HUMANS; IODINE RADIOISOTOPES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 0029859475     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tracy KJ and Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45: 491-503, 1994.
2. Donato NJ, Gallic GE, Steck PA and Rosenblum MG: Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. J Biol Chem 264: 20474-20481, 1989.
3. Donato NJ, Rosenblum MG and Steck PA: Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism. Cell growth & differ 3: 259-268, 1992.
4. Carpenter G: Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56: 881-914, 1987.
5. Carpenter G and Cohen S: Epidermal growth factor. Annu Rev Biochem 48: 193-219, 1979.
6. Velu TJ: Structure, function and transforming potential of the epidermal growth factor receptor. Mol cell Endocrinol 70: 205-216. 1990.
7. Bird TA and Saklatvala J: IL-1 and TNF transmodulate growth factor receptor by a protein kinase C-independent mechanism. J Immunol 142: 126-133, 1989.
8. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
9. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
10. Maio M, Gluwani B, Tombesi S, Langer JA, Duigou GJ, Kerbel RS, Fisher PB and Ferrone S: Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10. J Immunol 141: 913-920, 1988.
11. Norby JG, Ottolengihi P and Jensen J: Scatchard plot: common misinterpretation of binding experiments. Anal Biochem 102: 318-320, 1980.
12. Rosenthal HE: A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 20: 525-532, 1967.
13. Felder S, Miller K, Moehren G, Ullrich A, Schlessinger J and Hopkins CR: Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell 61: 623-634, 1990.
14. Sibely DR, Benovic JL, Caron MG and Lefkowitz RL: Regulation of transmembrane signalling by receptor phosphorylation, Cell 48: 913-922, 1978.
15. Kawamoto T, Mendelsohn J, Le A. Sato GH, Lazar CS and Gill GN: Regulation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J Biol Chem 259: 7761-7766, 1984.
16. Huslig RL, Mishra S and Hamburger AW. Interferon-enhancement of tyrosine phosphorylation of epidermal growth factor receptors in human breast carcinoma cells. Anticancer Res 13: 613-618, 1993.
17. Novotny-Smith CL, Zorbas MA, Mcisaac AM, Irimura T, Boman BM, Yeoman LC and Gallick GE: Down-modulation of epidermal growth factor receptor accompanies TNF-induced differentiation of the DiFi human adenocarcinoma cell line toward a goblet-like phenotype. J Cell Phys 157: 253-262, 1993.
18. Fish EN, Ghislain J, Trogadis J and Stevens JK: Inhibitory effect of α-interferon on epidermal growth factor-mediated receptor-dependent events. Cancer Res 53: 5148-5157, 1993.
19. Chakravarthy A, Chen LC, Mehta D and Hamburger AW: Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line. Anticancer Res 11: 347-352, 1991.
20. Worm M, Makki A, Dippel E, Czarnetzki BM and Schadendorf D: Interferon-gamma down regulates epidermal growth factor receptor on human melanoma cells. Exp Dermatol 4: 30-35, 1995.
21. Budillon A, Tagliaferii P, Caraglia M, Torrsi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati L and Bianco AR: Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermal cancer cells. Cancer Res 51: 1294-1299, 1991.
22. Muhus VJ, Asphal W, Knapstein PG and Kreienberg R: Effects of interferon-γ on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines. J Cancer Clin Oncol 120: 27-34, 1994.
23. Hamburger AW and Pinnamaheni GD: Increased epidermal growth factor receptor gene expression by γ-interferon in a human breast cell line, Br J Cancer 64: 64-68, 1991.
24. Palombella VJ, Yamashiro DJ, Maxfield FR, Decker SJ and Vilcek J: Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts. J Biol Chem 262: 1950-1954, 1987.
25. Loetscher H, Pan YE, Lahm H, Gentz R, Brockhaus M, Tabuchi H and Lesslauer W: Molecular cloning and expression of the human 55 kd tumor necrosis factor. Cell 61: 351-359, 1990.
26. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW. Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ and Goeddle DV: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61: 361-370, 1990.